[go: up one dir, main page]

BR9509345A - Peptídeo preparação farmacéutica e processos para imunomodulação para preparação de um peptídeo - Google Patents

Peptídeo preparação farmacéutica e processos para imunomodulação para preparação de um peptídeo

Info

Publication number
BR9509345A
BR9509345A BR9509345A BR9509345A BR9509345A BR 9509345 A BR9509345 A BR 9509345A BR 9509345 A BR9509345 A BR 9509345A BR 9509345 A BR9509345 A BR 9509345A BR 9509345 A BR9509345 A BR 9509345A
Authority
BR
Brazil
Prior art keywords
peptide
preparation
immunomodulation
processes
pharmaceutical preparation
Prior art date
Application number
BR9509345A
Other languages
English (en)
Inventor
Hakan Bergstrand
Tomas Eriksson
Kostas Karabelas
Magnus Lindvall
Bengt Sarnstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9509345A publication Critical patent/BR9509345A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR9509345A 1994-10-14 1995-10-06 Peptídeo preparação farmacéutica e processos para imunomodulação para preparação de um peptídeo BR9509345A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
BR9509345A true BR9509345A (pt) 1997-11-25

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509345A BR9509345A (pt) 1994-10-14 1995-10-06 Peptídeo preparação farmacéutica e processos para imunomodulação para preparação de um peptídeo

Country Status (20)

Country Link
US (2) US6103697A (pt)
EP (1) EP0783519A1 (pt)
JP (1) JPH10507448A (pt)
AU (1) AU705364B2 (pt)
BR (1) BR9509345A (pt)
CA (1) CA2201479A1 (pt)
CZ (1) CZ111997A3 (pt)
EE (1) EE9700087A (pt)
FI (1) FI971499L (pt)
HU (1) HUT77118A (pt)
IL (1) IL115509A0 (pt)
IS (1) IS4459A (pt)
MX (1) MX9702666A (pt)
NO (1) NO971625L (pt)
PL (1) PL319631A1 (pt)
SE (1) SE9403526D0 (pt)
SK (1) SK46797A3 (pt)
TR (1) TR199501255A2 (pt)
WO (1) WO1996011943A1 (pt)
ZA (1) ZA958140B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
AU761083B2 (en) * 1998-06-03 2003-05-29 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
AU2006238906B2 (en) 2005-04-25 2013-04-11 Cadila Pharmaceuticals Ltd. Vaccine adjuvants
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0300031A4 (en) 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNODEPRESSANT PEPTIDES AND METHODS OF USE THEREOF.
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
WO1989010935A1 (en) * 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
JP3592709B2 (ja) 1990-09-11 2004-11-24 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダーマトファゴイデス（家塵ダニ）のアレルゲンのクローニングおよびシークエンシング
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
ATE444360T1 (de) 1991-10-16 2009-10-15 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
JP3908271B2 (ja) 1993-03-05 2007-04-25 エピミューン，インコーポレイティド Ｈｌａ−ａ２．１結合ペプチドおよびそれらの使用
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのｂ細胞エピトープ
WO1996001318A1 (en) 1994-07-05 1996-01-18 Steeno Research Group A/S Immunomodulators
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
WO1996011943A1 (en) 1996-04-25
FI971499A7 (fi) 1997-06-10
NO971625D0 (no) 1997-04-09
TR199501255A2 (tr) 1996-06-21
US6228374B1 (en) 2001-05-08
FI971499L (fi) 1997-06-10
HUT77118A (hu) 1998-03-02
PL319631A1 (en) 1997-08-18
SE9403526D0 (sv) 1994-10-14
EP0783519A1 (en) 1997-07-16
SK46797A3 (en) 1997-09-10
AU3713395A (en) 1996-05-06
US6103697A (en) 2000-08-15
NO971625L (no) 1997-05-30
JPH10507448A (ja) 1998-07-21
CA2201479A1 (en) 1996-04-25
FI971499A0 (fi) 1997-04-10
ZA958140B (en) 1997-06-27
EE9700087A (et) 1997-10-15
MX9702666A (es) 1997-06-28
CZ111997A3 (en) 1997-12-17
AU705364B2 (en) 1999-05-20
IS4459A (is) 1997-04-08
IL115509A0 (en) 1996-05-14

Similar Documents

Publication Publication Date Title
BR9509345A (pt) Peptídeo preparação farmacéutica e processos para imunomodulação para preparação de um peptídeo
PL320824A1 (en) Aerodol form of a preparation of peptides and proteins
BR9610248A (pt) Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
BR9700829A (pt) Uso de interferon consensus humano para a produção de um medicamento
EE9800255A (et) Peptiididel ja adjuvantidel baseeruv farmatseutiline kompositsioon immuunmodulatsiooni jaoks
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
BR9602705A (pt) Composto composição farmacéutica processo para a preparação de um composto e uso
IL128118A0 (en) Modified amino acids medicaments containing these compounds and processes for their preparation
IL139235A0 (en) Pharmaceutical preparations
BR9608956A (pt) Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto
BR9601028A (pt) Compostos processo para sua preparação processo para a produção de preparações farmacêuticas preparação farmacêutica medicamento e uso
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
PT1003478E (pt) Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
BR9602933A (pt) Compostos processos para preparação de composto e de composição farmacêutica e composto
ATE233090T1 (de) Darifenacin enthaltende pharmazeutische zubereitungen
BR9608908A (pt) Composto composição farmacêutica processos para aliviar dor e para preparar um composto
BR9607095A (pt) Composto composição farmacêutica e processos para fabricar e para administrar um composto
BR9610821A (pt) Derivado de aminoácido uso de um composto e medicamento contendo o mesmo
BR9504463A (pt) Processo para preparaçao de lipossomas de quetoprofeno e preparaçoes farmacêuticas
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
BR9610733A (pt) Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]